Trou­bled aTyr ax­es 30% of its staff as it wipes a pre­clin­i­cal slate clean

Faced with dis­ap­point­ing re­sults from its lat­est pre­clin­i­cal pro­gram, aTyr Phar­ma is cut­ting the de­vel­op­ment short and let­ting go around 30% of its staff. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER